Medical News

RSS

Men's magazines don’t inform men about prostate and colon cancer screening

Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men’s magazines.

8 Sep 2004

Depressed patients may need treatment for both physical and emotional symptoms

Physical symptoms (such as headache, back pain, stomach problems, joint or muscle pains, and dizziness) are nearly as common in depression as emotional symptoms and are the predominant complaint depressed patients present with in the primary care setting.

8 Sep 2004

Genomic researchers and Canadian cancer treatment specialists meet in Halifax in order to improve cancer treatment outcomes

The Canadian Association of Radiation Oncologists and leading genomic cancer researchers will meet, Thursday, September 9 to 12th, 2004 at the Westin Nova Scotian Hotel in Halifax, to present research studies' results and to confer on methods to zero in on how to begin to utilize genomics, proteomics, and radiation, to improve cancer treatment outcomes for patients.

8 Sep 2004

International Committee of Medical Journal Editors will require registration of clinical trials for publication

The International Committee of Medical Journal Editors (ICMJE) issued a statement today that the 11 member journals will require, as a condition of consideration for publication, registration in a public trials registry for clinical studies involving human patients.

8 Sep 2004

Hospitals should use latex medical gloves with lower protein and powder levels to reduce latex sensitivity rather than synthetic alternatives

The non-profit, independent evaluator of medical devices notes that while some synthetic alternatives may cost less, latex gloves are still the most cost-effective choice when a glove offering a good level of protection is required.

8 Sep 2004

Study shows that naturopathic medicine helps women experiencing jaw pains

A study involving a painful jaw disorder and the role of naturopathic medicine demonstrates how this holistic approach to care can empower patients to improve their own health.

8 Sep 2004

Scientist rewarded for breaking down transplant rejection

A scientist from Australia's Monash University who has recently determined the structure of drug that is widely used as an immunosuppressant, will be presented the 2004 Science Minister's Prize for Life Scientist of the Year.

8 Sep 2004

Red-headed women are enjoying a new status as sex symbols

Ms Third, a natural red head, said flame-haired women have begun to surpass the stereotypical Aussie icon of the blonde hair, blue-eyed beach bunny in the sex appeal stakes.

8 Sep 2004

Gene therapy holds much promise for treating aggressive human superficial bladder cancer

Gene therapy that causes the bladder to act like a “bioreactor” to produce and secrete the anti-cancer agent interferon-alpha has shown dramatic benefits in preclinical tests, say researchers at The University of Texas M. D. Anderson Cancer Center.

8 Sep 2004

Researchers uncover how HIV causes abnormalities in antibody-producing cells

HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells—CD4+ T cells—whose destructive relationship with HIV has been well-studied by AIDS researchers.

8 Sep 2004

Researchers keep milk free of contaminants

Dairy farms in the United States produced more than 170 billion pounds of milk last year. The more than 9 million cows that produced that milk occasionally need to be treated for various ailments

8 Sep 2004

Japanese research lab to use an IBM supercomputer for protein research

IBM announced today that AIST, a leading Japanese research laboratory, will use an IBM BlueGene/L supercomputer to advance their research in proteins, potentially accelerating breakthroughs in drug design. The BlueGene/L supercomputer has been ranked as the fourth largest supercomputer in the world.

8 Sep 2004

Study shows lasers safely and effectively treat eye conditions in children

The first study to document the safety and effectiveness of the use of excimer lasers to treat a variety of eye maladies in children was published today in the September edition of the Journal of Cataract & Refractive Surgery.

8 Sep 2004

Long-term outcomes for liver transplantation due to hepatitis C

A new study on liver transplants necessitated by the hepatitis C virus (the most common indication for this type of transplant) found that long-term outcomes are similar to patients receiving transplants due to other diseases.

8 Sep 2004

Bill Clinton is recovering after undergoing successful quadruple bypass surgery

Former U.S. President Bill Clinton is recovering after undergoing successful quadruple bypass surgery from New York Presbyterian Hospital; the first accredited Chest Pain Center in New York. His heart disease was extensive, with blockages in some arteries well over 90 percent, doctors said.

8 Sep 2004

University of Utah gets patent approval relating to methods of rapid nucleic acid amplification

The U.S. Patent and Trademark Office has issued the University of Utah U.S. patent No. U.S. 6,787,338 (the '338 patent) relating to methods of rapid nucleic acid amplification.

8 Sep 2004

NMT Medical announces favorable patent decision

NMT Medical today announced a favorable decision by the U.S. Patent and Trademark Office Board of Appeals relating to the Company's patent infringement actions against AGA Medical Corp.

8 Sep 2004

Phase I clinical trial of new drug for severe asthma

Cambridge Antibody Technology today announced that it is starting a Phase I clinical trial of CAT-354, a human anti-IL-13 monoclonal antibody, which is a potential treatment for severe asthma, following recent approval from the Medicines and Healthcare products Regulatory Agency (MHRA).

8 Sep 2004

MorphoSys obtains license on human cell line technology for use in its antibody research

MorphoSys has announced today a non-exclusive license agreement with Dutch biotechnology company Crucell and DSM Biologics.

8 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004